全文获取类型
收费全文 | 71572篇 |
免费 | 5171篇 |
国内免费 | 190篇 |
专业分类
耳鼻咽喉 | 937篇 |
儿科学 | 1958篇 |
妇产科学 | 1759篇 |
基础医学 | 11830篇 |
口腔科学 | 1948篇 |
临床医学 | 6738篇 |
内科学 | 13788篇 |
皮肤病学 | 1458篇 |
神经病学 | 6958篇 |
特种医学 | 3018篇 |
外国民族医学 | 45篇 |
外科学 | 9477篇 |
综合类 | 626篇 |
一般理论 | 89篇 |
预防医学 | 5413篇 |
眼科学 | 1394篇 |
药学 | 5000篇 |
中国医学 | 163篇 |
肿瘤学 | 4334篇 |
出版年
2021年 | 1211篇 |
2020年 | 786篇 |
2019年 | 1098篇 |
2018年 | 1334篇 |
2017年 | 925篇 |
2016年 | 1102篇 |
2015年 | 1273篇 |
2014年 | 1627篇 |
2013年 | 2671篇 |
2012年 | 3484篇 |
2011年 | 3536篇 |
2010年 | 2495篇 |
2009年 | 2071篇 |
2008年 | 3177篇 |
2007年 | 3345篇 |
2006年 | 3268篇 |
2005年 | 3138篇 |
2004年 | 3182篇 |
2003年 | 2924篇 |
2002年 | 2974篇 |
2001年 | 2211篇 |
2000年 | 2248篇 |
1999年 | 2053篇 |
1998年 | 965篇 |
1997年 | 795篇 |
1996年 | 602篇 |
1995年 | 696篇 |
1994年 | 593篇 |
1993年 | 653篇 |
1992年 | 1487篇 |
1991年 | 1419篇 |
1990年 | 1367篇 |
1989年 | 1345篇 |
1988年 | 1140篇 |
1987年 | 1142篇 |
1986年 | 1071篇 |
1985年 | 1009篇 |
1984年 | 725篇 |
1983年 | 676篇 |
1982年 | 508篇 |
1981年 | 481篇 |
1980年 | 433篇 |
1979年 | 657篇 |
1978年 | 401篇 |
1977年 | 390篇 |
1976年 | 321篇 |
1975年 | 399篇 |
1974年 | 441篇 |
1973年 | 369篇 |
1972年 | 356篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Melanie A. Krook Julie W. Reeser Gabrielle Ernst Hannah Barker Max Wilberding Gary Li Hui-Zi Chen Sameek Roychowdhury 《British journal of cancer》2021,124(5):880
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this review by highlighting the diversity of FGFR genomic alterations identified in human cancers and the current challenges associated with the development of clinical-grade molecular diagnostic tests to accurately detect these alterations in the tissue and blood of patients. The past decade has seen significant advancements in the development of FGFR-targeted therapies, which include selective, non-selective and covalent small-molecule inhibitors, as well as monoclonal antibodies against the receptors. We describe the expanding landscape of anti-FGFR therapies that are being assessed in early phase and randomised controlled clinical trials, such as erdafitinib and pemigatinib, which are approved by the Food and Drug Administration for the treatment of FGFR3-mutated urothelial carcinoma and FGFR2-fusion cholangiocarcinoma, respectively. However, despite initial sensitivity to FGFR inhibition, acquired drug resistance leading to cancer progression develops in most patients. This phenomenon underscores the need to clearly delineate tumour-intrinsic and tumour-extrinsic mechanisms of resistance to facilitate the development of second-generation FGFR inhibitors and novel treatment strategies beyond progression on targeted therapy.Subject terms: Cancer, Cancer 相似文献
3.
4.
Joanne L. Clarke Jenny Ingram Debbie Johnson Gill Thomson Heather Trickey Stephan U. Dombrowski Alice Sitch Fiona Dykes Max Feltham Christine MacArthur Tracy Roberts Pat Hoddinott Kate Jolly 《Maternal & child nutrition》2020,16(1)
The UK has low breastfeeding rates, with socioeconomic disparities. The Assets‐based feeding help Before and After birth (ABA) intervention was designed to be inclusive and improve infant feeding behaviours. ABA is underpinned by the behaviour change wheel and offers an assets‐based approach focusing on positive capabilities of individuals and communities, including use of a Genogram. This study aimed to investigate feasibility of intervention delivery within a randomised controlled trial (RCT). Nulliparous women ≥16 years, (n = 103) from two English sites were recruited and randomised to either intervention or usual care. The intervention – delivered through face‐to‐face, telephone and text message by trained Infant Feeding Helpers (IFHs) – ran from 30‐weeks' gestation until 5‐months postnatal. Outcomes included recruitment rates and follow‐up at 3‐days, 8‐weeks and 6‐months postnatal, with collection of future full trial outcomes via questionnaires. A mixed‐methods process evaluation included qualitative interviews with 30 women, 13 IFHs and 17 maternity providers; IFH contact logs; and fidelity checking of antenatal contact recordings. This study successfully recruited women, including teenagers, from socioeconomically disadvantaged areas; postnatal follow‐up rates were 68.0%, 85.4% and 80.6% at 3‐days, 8‐weeks and 6‐months respectively. Breastfeeding at 8‐weeks was obtained for 95.1% using routine data for non‐responders. It was possible to recruit and train peer supporters to deliver the intervention with adequate fidelity. The ABA intervention was acceptable to women, IFHs and maternity services. There was minimal contamination and no evidence of intervention‐related harm. In conclusion, the intervention is feasible to deliver within an RCT, and a definitive trial required. 相似文献
5.
Die Onkologie - Trotz Aufklärungsgespräch durch den behandelnden Arzt wird häufig eine große Diskrepanz hinsichtlich der Therapiezieleinschätzung zwischen Arzt- und... 相似文献
6.
7.
8.
9.
Factors predicting the development of pressure ulcers in an at‐risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial 下载免费PDF全文
10.